• The Human Virome's Permanent Mark

    Bio-IT World | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.

    Jun 5, 2015

  • Business The billion-dollar biotech

    Nature News & Comment | Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever.

    Jun 4, 2015

  • Celgene Bluebird Streamline CAR-T Partnership To Fight Myeloma

    Xconomy | The immuno-oncology field is moving fast these days, but the tough-to-treat blood cancer multiple myeloma has not been one of its early targets.

    Jun 4, 2015

  • Genomics England Names Four Finalist Companies to Begin Interpretation

    Bio-IT World News Brief | Genomics England today announced four finalist companies and one alternate that will begin working on the interpretation of the genomes of the first 8,000 patients participating in the 100,000 Genomes Project.  Congenica and Omicia will work in rare diseases, Nanthealth in cancer, and Wuxi Nextcode in both rare disease and cancer for this stage of the project. Lockheed Martin in partnership with Cypher Genomics is the alternate.

    Jun 3, 2015

  • BaseHealth Opens Its Genomic Health Engine to Outside Developers

    Bio-IT World | BaseHealth, an Illumina-associated company using genomic data to provide patients with personalized health recommendations, is shifting to a more behind-the-scenes model, releasing an open API to integrate its own analysis engine into third-party apps and health platforms.

    Jun 2, 2015

  • Invitae Launches Direct-to-Consumer Pricing

    Bio-IT World | Invitae Corporation today announced a patient pay price for its full menu of genetic tests. For $475 per indication, patients can pay for their own genetic tests if insurance coverage is not available. The price covers all of Invitae’s offerings in cancer, cardiology, neurology, pediatric genetics, hematology and other rare conditions

    Jun 1, 2015

  • May News and Product Briefs

    Bio-IT World | News and product briefs from around the industry, including a suite of new proteomics and lipidomics solutions from SCIEX, and new efforts at the Broad Institute to understand the mechanisms of cancer drug resistance.

    Jun 1, 2015

  • Google cloud strategy focuses on analyzing big data

    Computerworld | Google may not have caught up to Amazon in the cloud market, but that's OK, according to a Google executive. The company is heading in a slightly different direction with cloud computing that involves helping customers analyze their data.

    Jun 1, 2015

  • Definiens Launches Biomarker Datafication Services

    Bio-IT World News Brief | Definiens today launched a new suite of Biomarker Datafication Services for oncology clinical development programs. The package provides image analysis screening of tissue samples for exploratory screening, pharmacokinetics/pharmacodynamics, and companion diagnostic development.

    May 29, 2015

  • PacBio Aims for Haplotyped Whole Genome Assemblies in Partnership with RainDance

    Bio-IT World | Months after 10X Genomics came to market with a platform for reassembling 100-kilobase DNA fragments with an Illumina sequencer, Pacific Biosciences and RainDance Technologies have teamed up on their own barcoded long read solution that they say could outperform 10X on virtually every count.

    May 29, 2015

  • Strand LS Expands Cancer Profiling Service

    Bio-IT World News Brief | Strand Life Sciences announced an expanded StrandAdvantage pan-cancer genomic profiling service. The new version of StrandAdvantage will include a panel that examines 152 genes and pathways known to be impacted by existing targeted solid tumor therapies plus additional chemotherapeutic toxicity and resistance data.

    May 28, 2015

  • Juno Therapeutics Partners with Editas Medicine on CRISPR-Engineered Cancer Immunotherapies

    Bio-IT World | Biotech funding must be hot indeed when an 18-month-old immunotherapy company can pledge hundreds of millions to an 18-month-old genome editing company, but there's plenty of promise combining CAR T therapy with CRISPR technology — as rivals Novartis and Intellia Therapeutics made clear when they forged their own partnership this January.

    May 27, 2015

  • QIAGEN Launches NGS Clinical Insights Platform

    Bio-IT World News Brief | Yesterday afternoon QIAGEN announced the commercial launch of QIAGEN Clinical Insight (QCI), a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). The first two supported applications for the bioinformatics platform are in oncology, for somatic and hereditary cancer testing. 

    May 27, 2015